Hans Clevers, MD, PhD, is Professor of Molecular Genetics at Utrecht University and a leading figure in cell biology, molecular signaling, and stem cell research.
He clarified the key components of the Wnt pathway and identified LGR5 as a marker for intestinal stem cells, paving the way for organoid technology: 3D in vitro models that mimic human organs and have transformed biomedical research.
Trained in Utrecht, he has held leadership roles at the Hubrecht Institute, the Royal Netherlands Academy, and the Princess Máxima Center. Since 2022, he has led Roche's pRED project and founded the Institute of Human Biology in Basel.
